Lv2
150 积分 2024-09-14 加入
Hepatic stellate cell inhibition by angiotensin II receptor blocker mitigates liver injury and fibrosis via NF-κB-galectin-3 suppression in a rat nonalcoholic steatohepatitis model
2个月前
已完结
NAFLD and NASH: etiology, targets and emerging therapies
4个月前
已完结
Global perspective on nonalcoholic fatty liver disease and nonalcoholic steatohepatitis ‐ prevalence, clinical impact, economic implications and management strategies
4个月前
已完结
HLF 和 PPARα 轴通过源自肠道微生物群的细胞外囊泡调节代谢相关的脂肪肝疾病
4个月前
已完结
代谢功能障碍相关脂肪性肝病的自然病程和进展
4个月前
已完结
Early liver transplantation for severe alcohol-related hepatitis not responding to medical treatment: a prospective controlled study
4个月前
已关闭
HLF and PPARα axis regulates metabolic‐associated fatty liver disease through extracellular vesicles derived from the intestinal microbiota
4个月前
已完结
Galectin-3 in metabolic disorders: mechanisms and therapeutic potential
5个月前
已完结
Galectin-3 modulation of T-cell activation: mechanisms of membrane remodelling
6个月前
已完结
Cell death by phagocytosis
6个月前
已完结
皖公网安备34019202002308
